α-Glucosidase inhibitors 0.5–0.8 Weight neutral Frequent GI side effects, three times/day dosing, expensive Exenatide 0.5–1.0 Weight loss Injections, frequent GI side effects, expensive, little ...
The AACE released the 2026 update to its algorithm for the management of adults with type 2 diabetes. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, ...
Please provide your email address to receive an email when new articles are posted on . Dawkins: The American Heart Association (AHA) introduced cardiovascular-kidney-metabolic (CKM) syndrome in 2023.
For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...
Diabetes is a lifelong condition that requires people to carefully monitor and manage their blood glucose using a range of medical devices. With over 800 million people with diabetes in the world ...
Please provide your email address to receive an email when new articles are posted on . Time in range, time below range and glucose management indicator are three CGM metrics with limitations.
MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results